Interrogating the protein interactomes of RAS isoforms identifies PIP5K1A as a KRAS-specific vulnerability
Hema Adhikari(Washington University in St. Louis), Christopher M. Counter(Duke University)
Cited by 91
Related Papers
Distinct requirements for Ras oncogenesis in human versus mouse cells
|Genes & Development|2002|422
Tumour maintenance is mediated by eNOS
|Nature|2008|320
A Landscape of Therapeutic Cooperativity in KRAS Mutant Cancers Reveals Principles for Controlling Tumor Evolution
|Cell Reports|2017|86
Rare codons capacitate Kras-driven de novo tumorigenesis
|Journal of Clinical Investigation|2014|78